Zobrazeno 1 - 10
of 9 528
pro vyhledávání: '"Lipids"'
Publikováno v:
Research Results in Pharmacology, Vol 2, Iss 1, Pp 4-8 (2016)
Research Results in Pharmacology 2(1): 4-8
Research Results in Pharmacology 2(1): 4-8
Using the combined application of L-arginine with HMG-Co-A reductase inhibitors simvastatin, atorvastatin, rosuvastatin and nanoparticulated rosuvastatin on the background of modeling of sepsis-induced disease through the introduction of strain 603 S
Autor:
David Chieng, Peter M. Kistler
Publikováno v:
Trends in Cardiovascular Medicine. 32:399-405
Coffee and tea are amongst the most consumed beverages worldwide, and are the main source of caffeine in adults. In this review we present findings on the effects of habitual coffee and tea consumption on cardiovascular disease (CVD) prevention. Mild
Autor:
Irma Karabegović, Wichor M. Bramer, Sara Beigrezaei, Macarena Lara, Auke J.C.F. Verkaar, Mojgan Amiri, Anniek C. van Westing, Trudy Voortman
Publikováno v:
Maturitas, 155, 40-53. Elsevier Ireland Ltd
Maturitas, 155, 40-53
Maturitas 155 (2022)
Maturitas, 155, 40-53
Maturitas 155 (2022)
Objectives Menopause is accompanied by many metabolic changes, increasing the risk of cardiometabolic diseases. The impact of diet, as a modifiable lifestyle factor, on cardiovascular health in general populations has been well established. The purpo
Autor:
Guy T'Sjoen, Martin den Heijer, Alessandra D. Fisher, Christel J. M. de Blok, Jaap Seidell, Maartje Klaver, Thomas Schreiner, Jos W. R. Twisk, Justine Defreyne, Renée de Mutsert, Daan M. van Velzen, Nota Nienke, Chantal M. Wiepjes
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
The Journal of clinical endocrinology and metabolism, 107(1), e153-e164. The Endocrine Society
The Journal of clinical endocrinology and metabolism, 107(1), e153-e164. Oxford University Press
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
The Journal of Clinical Endocrinology & Metabolism, 107(1), E153-E164. ENDOCRINE SOC
Klaver, M, van Velzen, D, de Blok, C, Nota, N, Wiepjes, C, Defreyne, J, Schreiner, T, Fisher, A, Twisk, J, Seidell, J, T'Sjoen, G, den Heijer, M & de Mutsert, R 2022, ' Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy ', The Journal of clinical endocrinology and metabolism, vol. 107, no. 1, pp. e153-e164 . https://doi.org/10.1210/clinem/dgab616
Klaver, M, van Velzen, D, de Blok, C, Nota, N, Wiepjes, C, Defreyne, J, Schreiner, T, Fisher, A, Twisk, J, Seidell, J, t'Sjoen, G, den Heijer, M & de Mutsert, R 2022, ' Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy ', The Journal of clinical endocrinology and metabolism, vol. 107, no. 1, pp. e153-e164 . https://doi.org/10.1210/clinem/dgab616
The Journal of clinical endocrinology and metabolism, 107(1), e153-e164. The Endocrine Society
The Journal of clinical endocrinology and metabolism, 107(1), e153-e164. Oxford University Press
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
The Journal of Clinical Endocrinology & Metabolism, 107(1), E153-E164. ENDOCRINE SOC
Klaver, M, van Velzen, D, de Blok, C, Nota, N, Wiepjes, C, Defreyne, J, Schreiner, T, Fisher, A, Twisk, J, Seidell, J, T'Sjoen, G, den Heijer, M & de Mutsert, R 2022, ' Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy ', The Journal of clinical endocrinology and metabolism, vol. 107, no. 1, pp. e153-e164 . https://doi.org/10.1210/clinem/dgab616
Klaver, M, van Velzen, D, de Blok, C, Nota, N, Wiepjes, C, Defreyne, J, Schreiner, T, Fisher, A, Twisk, J, Seidell, J, t'Sjoen, G, den Heijer, M & de Mutsert, R 2022, ' Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy ', The Journal of clinical endocrinology and metabolism, vol. 107, no. 1, pp. e153-e164 . https://doi.org/10.1210/clinem/dgab616
Introduction Excess visceral fat increases the risk of type 2 diabetes and cardiovascular disease and is influenced by sex hormones. Our aim was to investigate changes in visceral fat and the ratio of visceral fat to total body fat (VAT/TBF) and thei
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background The cardioprotective ability of n-3 polyunsaturated fatty acids (PUFAs) is controversial. Most studies suggest a specific role for PUFAs in cardioprotection from ischemic heart disease (IHD). However, few studies have used genetic biomarke
Autor:
Winfried März, Andreas Leiherer, Antti Jylhä, Axel Mündlein, Heinz Drexel, Christoph H. Säly, Eva Maria Brandtner, Marcus E. Kleber, Arthur Mader, Alexander Vonbank, Peter Fraunberger, Mitja Lääperi, Jörn F Dopheide, Reijo Laaksonen, Hana Ramadani
Publikováno v:
Journal of Internal Medicine. 290:1249-1263
Aims Peripheral arterial disease (PAD) and coronary artery disease (CAD) are both caused by atherosclerosis. Serum lipids and lipoproteins are predictive of the development of atherosclerosis but it is not clear if they differ in the two manifestatio
Autor:
Alice H. Lichtenstein, Edward Saltzman, Jiantao Ma, Paul F. Jacques, Caleigh M Sawicki, Gail Rogers, Nicola M. McKeown
Publikováno v:
The Journal of Nutrition
Background Greater whole grain (WG) consumption is associated with reduced risk of cardiovascular disease (CVD); however, few prospective studies have examined WG or refined grain (RG) intake and intermediate cardiometabolic risk factors. Objectives
Publikováno v:
The American Journal of Medicine. 135:426-429
The use of statin therapy in atherosclerotic cardiovascular disease (ASCVD) has demonstrated substantial improvement in morbidity and mortality of the aging population. Despite exhaustive studies demonstrating the benefits of statin therapy linking l
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-13 (2021)
Journal of Translational Medicine
Journal of Translational Medicine
Background Understanding the distinct patterns (trajectories) of variation in blood lipid levels before diagnosing cardiovascular disease (CVD) might carry important implications for improving disease prevention or treatment. Methods We investigated
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 32:447-455
BackgroundPrevious studies, in which the data were collected about half a century ago, suggested that elevated low density lipoprotein cholesterol (LDL-C) is not associated with increased risk of cardiovascular disease (CVD) in patients over 70 years